DNMT3A and neoplasm: mTORC2 integrates aberrant RTK signaling with environmental nutrient levels to regulate histone modifications and promote tumor growth, driving the hypomethylator phenotype by epigenetically regulating DNMT3A, which in turn remodels the tumor-supportive glutamate metabolism network [45].